Potential treatment pathway for genetic form of ALS and FTD

arrow down
New preclinical research shows promise for a potential treatment pathway aimed at slowing the disease process and extending survival in patients with ALS, often called Lou Gehrig’s disease, an insidious neurological condition.

Online version with high-res image available here: https://www.cell.com/neuron/fulltext/S0896-6273(19)30970-5

Scroll to Top